Skip to content

Exploring TIMP2 genetics and CSF levels in Parkinson's disease: biomarkers of neurodegeneration and ageing.

Sep 2026 · GeroScience · 0 citations · 16 references
Medicine

TL;DR

CSF TIMP2 levels primarily reflect ageing-related processes associated with neurodegeneration rather than disease-specific effects, and support a role of extracellular matrix-related ageing mechanisms in PD and related disorders.

View source

Similar papers

Open access Sep 2026

Lysosomal Expression Profile in Plasma Associates with Disease Severity in Parkinson's Disease.

These findings support the use of pathway-specific biomarkers for improving PD diagnostics and monitoring disease progression and support the use of pathway-specific biomarkers for improving PD diagnostics and monitoring disease progression.

Janna van Wetering, M. V. van Ingen, Evelien Timmermans et al. · 0 citations
Open access Oct 2026

Increased CSF PKR activation in Alzheimer’s disease is associated with APOE4 genotype

Protein kinase R (PKR) is a stress-activated kinase implicated in translational control, neuroinflammation, and neurodegeneration. Although increased PKR activation was reported in Alzheimer’s disease (AD), prior studies relied on semi-quantitative methods. This study aimed to quantitatively assess cerebrospinal...

Laurine Duquesne, A. Vrillon, Matthieu Martinet et al. · 0 citations
Open access 2026

Cerebrospinal Fluid Neuroinflammatory Biomarkers and Motor Symptom Severity in Early-Stage Parkinson’s Disease: A Cross-Sectional Analysis of the PPMI Cohort

It is suggested that CSF neuroinflammatory biomarkers were not associated with early motor severity in this sample of early-stage PD patients, and future research should examine whether these markers are more closely associated with other domains such as cognitive decline.

Harshal Lingineni · 0 citations
Open access Sep 2026

Associations between cerebrospinal fluid biomarkers related to endothelial dysfunction and Alzheimer’s disease

Background Although associations between overt vascular injury and Alzheimer’s disease (AD) have been reported, the role of subclinical vascular injury in dementia pathogenesis remains unclear. Cerebrospinal fluid (CSF) biomarkers related to endothelial dysfunction may capture subclinical vascular impairment and provid...

Yang-Ke Zhu, Qiu-Jie Zhu, Lan-Yang Wang et al. · 0 citations
Open access Sep 2026

Exploratory mediation analysis of associations between serum biomarkers of neuronal injury, astrocyte reactivity, neuroinflammation, and neurotrophic support and fatigue in Parkinson's disease

Introduction and aim. Fatigue is a debilitating non-motor symptom in Parkinson's disease (PD). This exploratory cross-sectional mediation analysis investigated whether specific serum biomarkers mediate the relationship between PD and fatigue severity. Material and methods. Ninety PD patients and 45 matched controls we...

T. Al-Naqeeb, H. Al-hakeim · 0 citations
Open access Sep 2026

Health-related factors and their impact on blood-based biomarkers of Alzheimer's disease

In CSF-confirmed participants, age emerged as the most consistent predictor of plasma biomarker levels, particularly NFL and pTau181, which suggests that plasma biomarkers are influenced primarily by age and genetic background rather than by metabolic factors in this cohort.

Carolin I. Kurz, Marleen Taute, Paulina Tegethoff et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.